The Alabama Center for Childhood Cancer and Blood Disorders is a partnership between Children’s of Alabama and the UAB Division of Pediatric Hematology-Oncology. More than a dozen highly-specialized pediatric hematologists, oncologists and blood and marrow transplant physicians at Children’s provide care to infants through young adults up to age 25. Our multidisciplinary team approach provides family-centered treatment and support through a variety of innovative services from the day of diagnosis through treatment, cure and long-term follow-up..
The Alabama Center for Childhood Cancer and Blood Disorders is the state's only comprehensive pediatric center, treating 90 percent of all pediatric cancer and other blood disorders patients diagnosed in Alabama and offering specific treatment and research programs for:
- Pediatric Oncology (Childhood and Young Adult Cancer)
- Pediatric Hematology (Blood Diseases, including Sickle Cell Disease)
- Neuro-Oncology (Brain and Spinal Cord Tumors)
- Pediatric Blood and Marrow Transplantation Program
- Developmental Therapeutics Program
- Childhood Cancer Survivorship Program (Taking On Life After Cancer)
- Hope and Cope Psychosocial Program
- Pediatric Hematology-Oncology Fellowship Training Program
The Alabama Center for Childhood Cancer and Blood Disorders is an active member institution of Children's Oncology Group (COG) an international 200 member collaborative academic research group focused on clinical trials in childhood cancer. The Division has been awarded membership in the COG Phase I Consortium. This prestigious designation is important as the Children's of Alabama is now one of only 21 COG Phase I Consortium Sites in the North America and allows us to provide novel therapies for children with cancer.
More than 90 percent of all Alabama children diagnosed with cancer or a serious blood disorder are treated at Children’s of Alabama.
- 130 children were newly diagnosed with cancer
- 300 cancer patients under active treatment
- 13,000+ outpatient clinic visits
- 25-30 young people received blood or bone marrow transplants
- 2,000+ patients treated for other serious blood disorders, including sickle cell disease, hemophilia and bleeding disorders